References
- Tsai JH, Derby E, Holland EJ, et al. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 2006;25:530–532
- Cheng JW, Cheng SW, Gao LD, et al. Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: A systematic review and meta-analysis. PLoS One 2012;7:e45079
- Holland EJ, Schwartz GS. The Paton lecture: Ocular surface transplantation: 10 years’ experience. Cornea 2004;23:425–431
- Oltra EZ, Djalilian AR, Wilensky JT. Diode laser transscleral cyclophotocoagulation after keratolimbal allograft transplantation. Presented as a scientific poster at: The American Academy of Ophthalmology Annual Meeting, October 24, 2011, Orlando, FL, USA
- Schwartz GS, Holland EJ. Iatrogenic limbal stem cell deficiency: When glaucoma management contributes to corneal disease. J Glaucoma 2001;10:443–445
- Alvarenga LS, Mannis MJ, Brandt JD, et al. The long-term results of keratoplasty in eyes with a glaucoma drainage device. Am J Ophthalmol 2004;138:200–205
- Lim KS. Corneal endothelial cell damage from glaucoma drainage device materials. Cornea 2003;22:352–354